
Opinion|Videos|April 28, 2025
Clinical Manifestation of ATTR-CM and Red Flag Symptoms
Panelists discuss how recognizing key clinical manifestations and red flag symptoms, such as bilateral carpal tunnel syndrome, spinal stenosis, and trigger fingers, is critical for early diagnosis and intervention in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), particularly in those with unexplained heart failure or arrhythmias.
Advertisement
Episodes in this series

Summary for Physicians: Clinical Manifestations and Red Flag Symptoms of ATTR-CM
Clinical Manifestations of ATTR-CM:
- Cardiac symptoms:
- Heart failure (HF), often with restrictive cardiomyopathy
- Atrial arrhythmias that are resistant to ablation procedures
- Bradyarrhythmias and tachyarrhythmias
- Pacemaker dependence in advanced cases
- Extracardiac symptoms:
- Bilateral carpal tunnel syndrome (CTS): Often a key early sign of the disease
- Spinal stenosis: May cause discomfort or neurological deficits
- Trigger fingers: Common in patients with hereditary transthyretin amyloid cardiomyopathy (hATTR-CM)
- Pulmonary embolism: Can occur in advanced stages
- Electrocardiogram findings:
- May show signs of low-voltage QRS complexes, heart block, or other arrhythmias typical of restrictive cardiomyopathy
- Imaging:
- Echocardiography and cardiac MRI often show characteristic features of restrictive cardiomyopathy or amyloid deposits.
- Chest x-ray may show evidence of HF.
- Laboratory findings:
- Elevated biomarkers such as NT-proBNP and troponins can be seen in cardiac involvement.
- Genetic testing can confirm the diagnosis of hATTR-CM.
Red Flag Symptoms for hATTR-CM:
- Persistent bilateral CTS, spinal stenosis, and trigger fingers should raise suspicion of hATTR-CM, especially in patients with unexplained HF or arrhythmias.
- A history of family members with similar symptoms or genetic mutations associated with ATTR-CM further supports the diagnosis.
Early recognition of these symptoms is essential for timely diagnosis and intervention in patients with ATTR-CM.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
European Society of Cardiology 2026 Preview: 6 Trials to Know
2
TNX-103 Misses Primary Endpoint in Phase 3 LEVEL PH-HFpEF Trial
3
The HCPFive: Top News for Healthcare Providers from the Week of 08/02
4
L-17 vs IL-23: Head-to-Head Data in Psoriasis and PsA
5






































































